DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sangro B, Gomez-Martin C, de la Mata M. , et al.
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.
J Hepatol 2013;
59 (01) 81-88
We do not assume any responsibility for the contents of the web pages of other providers.